AGPAT6 (1-acylglycerol-3-phosphate O-acyltransferase 6 (lysophosphatidic acid acyltransferase, zeta)) Blocking Peptide (the middle region of AGPAT6)(100ug)

Supplier: Aviva Systems Biology Incorporated

0 reviews | Write a Review Pencil

Description
Additional Information

This is a synthetic peptide designed for use in combination with anti-AGPAT6 Antibody (ARP60802_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.

Reactivities:	Human
Presku:	AAP60802
Size:	100ug
Weight:	52kDa
Gene:	137964
Format:	Lyophilized powder
Target:	Lysophosphatidic acid acyltransferases catalyze the conversion of lysophosphatidic acid (LPA) to phosphatidic acid (PA). LPA and PA are involved in signal transduction and lipid biosynthesis.
Alternative names:	DKFZp586M1819; LPAAT-zeta; LPAATZ; TSARG7